CLINICAL_TRIALS
trial_result
· 2012-05-21
Clinical Trial Update: Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis [Phase 3]
Summary
A Phase 3 study evaluating the efficacy and safety of lumiracoxib in primary hip osteoarthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Osteoarthritis, Hip | Phase 3 | Status: COMPLETED